Lycan, T., Thomas, A., Hsu, F.-C., Cartwright, M. S., Walker, F. O., Ahn, C., … Strowd, R. E. (2018). Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy. Journal of Clinical Oncology, 36(15_suppl), e22083–e22083. https://doi.org/10.1200/jco.2018.36.15_suppl.e22083

Lycan, Thomas, Alexandra Thomas, Fang-Chi Hsu, Michael Stephen Cartwright, Francis O. Walker, Christine Ahn, Omar P. Sangueza, et al. “Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy.” Journal of Clinical Oncology 36, no. 15_suppl (May 20, 2018): e22083–e22083. https://doi.org/10.1200/jco.2018.36.15_suppl.e22083.

Lycan T, Thomas A, Hsu F-C, Cartwright MS, Walker FO, Ahn C, et al. Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy. Journal of Clinical Oncology. 2018 May 20;36(15_suppl):e22083–e22083.

Lycan, Thomas, et al. “Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2018, pp. e22083–e22083. Crossref, doi:10.1200/jco.2018.36.15_suppl.e22083.

Lycan T, Thomas A, Hsu F-C, Cartwright MS, Walker FO, Ahn C, Sangueza OP, Shiozawa Y, Park SH, Peters CM, Melin SA, Avery TP, Sorscher S, Lesser GJ, Strowd RE. Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018 May 20;36(15_suppl):e22083–e22083.